Silver nanoparticles selectively treat triple‐negative breast cancer cells without affecting non‐malignant breast epithelial cells in vitro and in vivo

Silver nanoparticles (AgNPs) show promise for treatment of aggressive cancers including triple‐negative breast cancer (TNBC) in preclinical cancer models. For clinical development of AgNP‐based therapeutics, it will be necessary to clearly define the specific physicochemical features of the nanopart...

Descripción completa

Detalles Bibliográficos
Autores principales: Swanner, Jessica, Fahrenholtz, Cale D., Tenvooren, Iliana, Bernish, Brian W., Sears, James J., Hooker, Allison, Furdui, Cristina M., Alli, Elizabeth, Li, Wencheng, Donati, George L., Cook, Katherine L., Vidi, Pierre‐Alexandre, Singh, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996381/
https://www.ncbi.nlm.nih.gov/pubmed/32123812
http://dx.doi.org/10.1096/fba.2019-00021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996381/
https://www.ncbi.nlm.nih.gov/pubmed/32123812
http://dx.doi.org/10.1096/fba.2019-00021

Ejemplares similares